Antimicrobial Peptides and Emerging Tech Revolutionize Wound Healing Strategies

Chronic and non-healing wounds, such as diabetic ulcers and pressure sores, represent a significant global health burden, often leading to severe complications like infection and amputation. Current treatment modalities frequently fall short, highlighting an urgent need for more effective therapies. This comprehensive review addresses the critical knowledge gap by synthesizing advancements in molecular mechanisms, antimicrobial peptides (AMPs), and emerging regenerative technologies to improve wound care outcomes.

The review highlighted that antimicrobial peptides (AMPs) significantly accelerate wound closure and drastically reduce infection rates across various models. > Topical application of peptide-hydrogel composites consistently demonstrated a 45-60% faster wound closure compared to standard care or vehicle controls in preclinical studies (p<0.001). Specifically, LL-37 applied at 1 mg/kg daily was shown to reduce bacterial load by over 90% in infected wounds, while also promoting angiogenesis (new blood vessel formation) by 2.3-fold. Emerging technologies like 3D bioprinting and nanofiber scaffolds were found to enhance re-epithelialization by 2.5-fold and increase collagen deposition by 30-40% in in vitro and ex vivo models, indicating superior tissue regeneration.